SS
Steve Shuttleworth
Venture Partner at Samsara BioCapital
Bourne End, England
Overview
Steve Shuttleworth is a Venture Partner at Samsara BioCapital in Palo Alto, California, with a background in drug discovery and development. He has held leadership roles in companies like Topspin Therapeutics Inc. and Nalo Therapeutics, Inc., showcasing expertise in the pharmaceutical industry and oncology.
Shuttleworth's career highlights include serving as CEO and Co-Founder of Topspin Therapeutics Inc. (now Integer Bio Inc.) and as Chief Technology Officer at Nalo Therapeutics, Inc., demonstrating a track record of leadership in biotechnology and clinical development.
Work Experience
Venture Partner
2019 - Current
Samsara Biocapital provides investment advisory services to help entrepreneurs turn their own ideas and visions into successful companies.
Scientific Advisor
2019
Autobahn Labs is a biotechnology company that accelerates the development of novel therapeutics.
Director
2021
CTO
2019 - 2024
CEO and Co-Founder
2020 - 2022
Chair of The Scientific Advisory Board
2019 - 2020
CSO, COO and Executive Director
2017 - 2019
CSO and Executive Director
2008 - 2017
Honorary Professor, Molecular & Clinical Cancer Sciences, School of Medical Science
2014 - 2020
Non Executive Director
2019 - 2019
Head of New Projects Development
2006 - 2008
Director of Chemistry
2003 - 2006
Education
PhD
1991 - 1994
BSc (Hons)
1988 - 1991